Oleander Medical Technologies is Biotechnology in United States that focus on cancer cells business. Founded in 2012. They cover business area such as developer, cancer cell, late-stage cancer, surgery, chemotherapy, radiation, sodium ion, medical researcher, both normal and cancerous tissue, serious damage.
2012
( 12 years old in 2024 )
Cancer Cells
-
Louisiana Emerging Technology Center
340 East Parker Center
Baton Rouge, LA 70803
United States
Private
developercancer celllate-stage cancersurgerychemotherapyradiationsodium ionmedical researcherboth normal and cancerous tissueserious damage
* We use standard office opening hours in near Oleander Medical Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Oleander Medical Technologies is Biotechnology business from United States that founded in 2012 (12 years old in 2024), Oleander Medical Technologies business is focusing on Cancer Cells.
Oleander Medical Technologies headquarter office and corporate office address is located in Louisiana Emerging Technology Center 340 East Parker Center Baton Rouge, LA 70803 United States.
Oleander Medical Technologies was founded in United States.
In 2024, Oleander Medical Technologies is currently focus on cancer cells sector.
Above is snippet of Google Trends for "cancer cells" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Oleander Medical Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
